Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.

Kenshiro TakemotoYohei SekinoHiroyuki KitanoKenichiro IkedaKeisuke GotoKeisuke HiedaTetsutaro HayashiYasuhisa HasegawaMasao KatoYuichi KadonishiMitsuru KajiwaraJun TeishimaKoji MitaSatoshi MaruyamaMasanobu ShigetaNobuyuki Hinata

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

We showed the impact of both low and high BMI on predicting therapeutic efficacy and prognosis in mRCC patients treated with TKI.

Keyphrases

body mass index
metastatic renal cell carcinoma
weight gain
chronic myeloid leukemia
physical activity
tyrosine kinase
advanced non small cell lung cancer
newly diagnosed
weight loss
epidermal growth factor receptor